WITTYCELL has a total of 21 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Canada and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ONTORII INC, IDENIX PHARMACEUTICALS LLC and NuCana plc.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Republic of Korea | 2 | |
#6 | South Africa | 2 | |
#7 | Argentina | 1 | |
#8 | Brazil | 1 | |
#9 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Heterocyclic compounds | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Serra Vincent | 16 |
#2 | Vincent Serra | 4 |
Publication | Filing date | Title |
---|---|---|
EP2727929A1 | Method of preparation of alpha galactosyl ceramides compounds | |
CA2697993A1 | Methods of enhancing adjuvanticity of vaccine compositions | |
EP2060252A1 | New formulation of galactosylceramide derivatives | |
EP2058011A1 | Nkt cell activating gycolipids covalently bound antigens and/or drug |